Katsuichi Ohsawa
Director/Board Member at TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
Katsuichi Ohsawa active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. | Director/Board Member | 2019-05-31 | - |
| Corporate Officer/Principal | 2019-05-31 | - | |
Taisho Pharmaceutical Co., Ltd.
 Taisho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taisho Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Self-Medication, Prescription Pharmaceutical and Overseas Development. The Self-Medication division deals with the research, development, and production of over-the-counter (OTC) drugs, medical supplies, food for specific health use, and hygiene products. The Prescription Pharmaceutical division handles research and development of new drugs in the fields of central nervous system diseases, metabolic diseases, infectious diseases, and inflammatory diseases. The Overseas Development division markets energy drinks and OTC pharmaceuticals overseas. The company was founded on October 12, 1912 and is headquartered in Tokyo, Japan. | Director/Board Member | 2019-05-31 | - |
| Corporate Officer/Principal | 2007-03-31 | - |
Career history of Katsuichi Ohsawa
Statistics
International
| Japan | 3 |
Operational
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Taisho Pharmaceutical Co., Ltd.
Taisho Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Taisho Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Self-Medication, Prescription Pharmaceutical and Overseas Development. The Self-Medication division deals with the research, development, and production of over-the-counter (OTC) drugs, medical supplies, food for specific health use, and hygiene products. The Prescription Pharmaceutical division handles research and development of new drugs in the fields of central nervous system diseases, metabolic diseases, infectious diseases, and inflammatory diseases. The Overseas Development division markets energy drinks and OTC pharmaceuticals overseas. The company was founded on October 12, 1912 and is headquartered in Tokyo, Japan. | Health Technology |
- Stock Market
- Insiders
- Katsuichi Ohsawa
- Experience
